REG - Global Invacom Group - Appointment of Financial Adviser

Global InvacomAnnouncement

25/02/2019 09:45

RNS Number : 9910Q
Global Invacom Group Limited
25 February 2019
 


 
GLOBAL INVACOM GROUP LIMITED
(Incorporated in the Republic of Singapore)
 (Company Registration No. 200202428H)

 

 
APPOINTMENT OF FINANCIAL ADVISER FOR THE PROPOSED ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL OF TACTILIS SDN BHD

 

 
Unless otherwise defined, capitalised terms used in this Announcement shall have the same meaning
ascribed to them in the announcements dated 24 October 2018 and 31 October 2018.
 
 
1.   APPOINTMENT OF FINANCIAL ADVISER
 
The Board of Directors ("Board" or "Directors") of Global Invacom Group Limited ("Company") together with its subsidiaries ("Group") wishes to announce that the Group has appointed CEL Impetus Corporate Finance Pte Ltd as its financial adviser, to advise on the proposed acquisition by the Company of the entire issued share capital of Tactilis Sdn. Bhd.
 
This appointment is not expected to have any material impact on the consolidated net tangible assets per share and consolidated earnings per share of the Group.
 
 
2.   CAUTION IN TRADING
 
Shareholders and potential investors are advised to exercise caution in trading the Shares as there is no certainty or assurance as at the date of this Announcement that the Proposed Acquisition, Proposed Target Convertible Notes Subscription and/or Proposed RCN Issuance will be completed.
 
Shareholders are advised to read this Announcement and any past or further announcements by the Company carefully.  Shareholders should consult their stock brokers, bank managers, solicitors or other professional advisers if they have any doubt about the actions that they should take.
 
 
BY ORDER OF THE BOARD
 
 
Anthony Brian Taylor
Executive Chairman
 
 
25 February 2019
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCCKPDKCBKKDBB